Skip to main content

Table 2 Raw patient activation measurement (PAM) scores with 95% confidence intervals (CI) assessed after each follow-up consultation, i.e. 3, 6, 12, 18, 24, 36 and 48 months postoperatively. Each response is grouped according to the period with no electronic Patient-reported Outcomes (− ePRO) and the period supported by electronic Patient-reported Outcomes (+ ePRO)

From: Cancer follow-up supported by patient-reported outcomes in patients undergoing intended curative complex surgery for advanced cancer

 

Groups

 

− ePRO

n = 105

+ ePRO

n = 82

3 months

60.7 (57.5, 63.9)

(n = 41)

61.1 (57.4, 64.8)

(n = 27)

6 months

58.7 (53.9, 63.6)

(n = 23)

58.7 (53.8, 63.6)

(n = 28)

12 months

58.9 (54.2, 61.7)

(n = 38)

58.0 (54.7, 61.2)

(n = 36)

18 months

55.6 (51.0, 60.2)

(n = 20)

63.3 (56.4, 70.3)

(n = 20)

24 months

59.8 (52.4, 67.1)

(n = 8)

58.6 (50.4, 63.9)

(n = 17)

36 months

65.0 (56.7, 73.3)

(n = 12)

58.6 (51.5, 65.8)

(n = 17)

48 months

51 (NA)

(n = 1)

58 (43.9, 72.1)

(n = 9)